MMRF CoMMpass Study
Who can participate in the MMRF CoMMpass℠ study?
Patients may be able to take part in the MMRF CoMMpass℠ study if they are at least 18 years of age and have been recently diagnosed with multiple myeloma.
If you are a multiple myeloma patient interested in participating, ask your doctor if you meet the rules for inclusion in the study.
What are the Benefits of participation?
The information gathered from this study will help doctors and scientists learn more about multiple myeloma and develop more effective and safe treatments, which may help others with the disease in the future. By participating in the CoMMpass℠ study patients will help accelerate the discovery and development of the next generation of multiple myeloma treatments.
Participation in the study is voluntary and patients can leave the study at any time.
What should patients consider before taking part in the MMRF CoMMpass℠ study?
There are many factors to weigh before deciding to participate in the CoMMpass℠ study. As with any study, there are risks to participating. Discuss these risks with your doctor. Taking part in the CoMMpass℠ study will not improve the health outcomes of study participants. Patients may not receive any quantifiable benefits from being part of this study.
What will you have to do as part of this study?
At each of the regular study visits (every 3 months), participants will undergo the usual tests associated with their treatment. Doctors will collect small amounts of blood and bone marrow for this study. Please note that study participants will not have to undergo a separate procedure for sample collection.
Patients will also be asked to complete a questionnaire about their health and lifestyle.
How do I find out more?
Patients who are interested in learning more about the MMRF CoMMpass℠ study and whether they qualify, should call 866-603-6628 or email firstname.lastname@example.org.